UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Sinus surgery postpones chronic Gram-negative lung infection: cohort study of 106 patients with cystic fibrosis

Rhinology, 2016-09, Vol.54 (3), p.206-213

2016

Volltextzugriff (PDF)

Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes

Molecular microbiology, 2008-04, Vol.68 (1), p.223-240

2008

Volltextzugriff (PDF)

In Situ Growth Rates and Biofilm Development of Pseudomonas aeruginosa Populations in Chronic Lung Infections

Journal of Bacteriology, 2008-04, Vol.190 (8), p.2767-2776

2008

Volltextzugriff (PDF)

P247 Advances in cystic fibrosis lung infection modeling: profiling microbial interactions at micro-scale distances

Journal of cystic fibrosis, 2024-06, Vol.23, p.S144-S144

2024

Volltextzugriff (PDF)

Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth

Microbes and infection, 2001, Vol.3 (1), p.23-35

2001

Volltextzugriff (PDF)

Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review?

The Journal of hospital infection, 2007-04, Vol.65 (4), p.374-375

2007

Volltextzugriff (PDF)

A new device to prevent contamination of nasal swabs by Staphylococcus aureus in acute rhinosinutitis

Rhinology (Amsterdam), 2020-05, Vol.3 (3), p.39-44

2020

Volltextzugriff (PDF)

503 Bacterial characteristics and metabolism of persistent methicillin-resistant Staphylococcus aureus infection

Journal of cystic fibrosis, 2022-10, Vol.21, p.S284-S284

2022

Volltextzugriff (PDF)

EPS3.03 Using airway organoids and Air Liquid Interface cultures to profile the spatial and temporal dynamics of Pseudomonas aeruginosa infections

Journal of cystic fibrosis, 2021, Vol.20, p.S35-S36

2021

Volltextzugriff (PDF)

EPS3.06 Ceftolozane/tazobactam: a new drug with superior effect against resistant P. aeruginosa

Journal of cystic fibrosis, 2021, Vol.20, p.S36-S37

2021

Volltextzugriff (PDF)

ePS6.05 Combat of resistance development with collateral sensitivity of Pseudomonas aeruginosa cystic fibrosis lung isolates

Journal of cystic fibrosis, 2019-06, Vol.18, p.S54-S54

2019

Volltextzugriff (PDF)

P132 Reduced systemic immune responses in cystic fibrosis patients

Journal of cystic fibrosis, 2021, Vol.20, p.S79

2021

Volltextzugriff (PDF)

ePS3.03 Using patient-derived airway models to study Pseudomonas aeruginosa colonisation and infection

Journal of cystic fibrosis, 2022-06, Vol.21, p.S49-S50

2022

Volltextzugriff (PDF)

P036 A comparative study of cell culture inserts for in vitro modeling of the cystic fibrosis airway epithelium

Journal of cystic fibrosis, 2023-06, Vol.22, p.S74-S74

2023

Volltextzugriff (PDF)

WS08.5 Omics-based surveillance of Pseudomonas aeruginosa infection identifies clonal persistence despite ‘eradication’

Journal of cystic fibrosis, 2020-06, Vol.19, p.S14-S14

2020

Volltextzugriff (PDF)

P084 Counteracting inflammation triggered by Pseudomonas aeruginosa-ctivated lung-infiltrating Th1/17 cells: a novel approach for precision medicine in cystic fibrosis

Journal of cystic fibrosis, 2022-06, Vol.21, p.S86

2022

Volltextzugriff (PDF)

Sinus surgery postpones chronic Gram-negative lung infection: cohort study of 106 patients with cystic fibrosis

Rhinology, 2017-01, Vol.54 (3), p.206-213

2017

Volltextzugriff (PDF)

Has the new technology made Gram's staining method redundant? The Danish Society of Clinical Microbiology

Ugeskrift for læger, 2008-03, Vol.170 (12), p.1041

2008

Volltextzugriff (PDF)

Allotypes of α1-antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508

Pediatric pulmonology, 1994-07, Vol.18 (1), p.3-7

1994

Volltextzugriff (PDF)

112 Telithromycin inhibits the production of virulence factors and biofilm formation of P. aeruginosa without affecting its proliferation in vitro

Journal of cystic fibrosis, 2006, Vol.5, p.S25-S25

2006

Volltextzugriff (PDF)

Is new prescription of antibiotics after treatment with sulfonamide or pivmecillinam a validated method for assessment of treatment failure?

Ugeskrift for læger, 2002-02, Vol.164 (7), p.920

2002

Volltextzugriff (PDF)

Allotypes of alpha 1-antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508

Pediatric pulmonology, 1994-07, Vol.18 (1), p.3-7

1994

Volltextzugriff (PDF)

Diagnosis of infectious diseases. Pneumonia

Ugeskrift for læger, 2001-11, Vol.163 (45), p.6259

2001

Volltextzugriff (PDF)

The clinical impact of bacterial biofilms

International journal of oral science, 2011-04, Vol.3 (2), p.55-65

2011

Volltextzugriff (PDF)

Evolutionary dynamics of bacteria in a human host environment

Proceedings of the National Academy of Sciences - PNAS, 2011-05, Vol.108 (18), p.7481-7486

2011

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(76)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(46)
Humans
(39)
Biological And Medical Sciences
(24)
Cystic Fibrosis
(21)
Female
(21)
Pseudomonas Aeruginosa
(21)
Animals
(19)
Microbiology
(19)
Medical Sciences
(18)
Immunology
(15)
Infectious Diseases
(14)
Adult
(12)
Male
(12)
Cystic Fibrosis - Complications
(11)
Cystic Fibrosis - Microbiology
(11)
Rats
(11)
Chronic Disease
(10)
Pseudomonas Infections - Microbiology
(10)
Adolescent
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Sinus surgery postpones chronic Gram-negative lung infection: cohort study of 106 patients with cystic fibrosis

Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes

In Situ Growth Rates and Biofilm Development of Pseudomonas aeruginosa Populations in Chronic Lung Infections

P247 Advances in cystic fibrosis lung infection modeling: profiling microbial interactions at micro-scale distances

Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth

Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review?

A new device to prevent contamination of nasal swabs by Staphylococcus aureus in acute rhinosinutitis

503 Bacterial characteristics and metabolism of persistent methicillin-resistant Staphylococcus aureus infection

EPS3.03 Using airway organoids and Air Liquid Interface cultures to profile the spatial and temporal dynamics of Pseudomonas aeruginosa infections

EPS3.06 Ceftolozane/tazobactam: a new drug with superior effect against resistant P. aeruginosa

ePS6.05 Combat of resistance development with collateral sensitivity of Pseudomonas aeruginosa cystic fibrosis lung isolates

P132 Reduced systemic immune responses in cystic fibrosis patients

ePS3.03 Using patient-derived airway models to study Pseudomonas aeruginosa colonisation and infection

P036 A comparative study of cell culture inserts for in vitro modeling of the cystic fibrosis airway epithelium

WS08.5 Omics-based surveillance of Pseudomonas aeruginosa infection identifies clonal persistence despite ‘eradication’

P084 Counteracting inflammation triggered by Pseudomonas aeruginosa-ctivated lung-infiltrating Th1/17 cells: a novel approach for precision medicine in cystic fibrosis

Sinus surgery postpones chronic Gram-negative lung infection: cohort study of 106 patients with cystic fibrosis

Has the new technology made Gram's staining method redundant? The Danish Society of Clinical Microbiology

Allotypes of α1-antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508

112 Telithromycin inhibits the production of virulence factors and biofilm formation of P. aeruginosa without affecting its proliferation in vitro

Is new prescription of antibiotics after treatment with sulfonamide or pivmecillinam a validated method for assessment of treatment failure?

Allotypes of alpha 1-antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508

Diagnosis of infectious diseases. Pneumonia

The clinical impact of bacterial biofilms

Evolutionary dynamics of bacteria in a human host environment

Suchergebnisse filtern